早产儿视网膜病变治疗新进展

早产儿视网膜病变(retinopathy of prematurity，ROP)是早产儿和低体质量儿发生的一种视网膜血管增生性病变。近年来随着医疗护理水平不断提高，早产儿的存活率不断提高，ROP的发生率也明显增加。传统治疗方式包括冷冻治疗和激光治疗，这些治疗对操作医生的技术有较高的要求。因此，寻找一种在病变早期应用，且操作简单、安全、有效的治疗方法，已成为研究者的共识。我们就目前治疗ROP的新进展进行综述。

Current treatment progress on retinopathy of prematurity

Retinopathy of prematurity(ROP)is a disease of retinal vascular proliferative lesions which occurs in premature and low birth weight infants. The incidence is increasing in view of the rising numbers of preterm deliveries and improved neonatal care. Traditional modalities of treatment include cryotherapy and laser therapy, which are laborious and require special training. Hence, research is on the way to find novel treatment modalities used for early stage of the disease with the characteristics of easy operation, safety and efficacy. We reviewed the published and unpublished literature on newer methods of ROP management.